Evidence map›Paper›PMID 32276474›Full record

ArticleMedicines (Basel, Switzerland)2020

Piperine Inhibits TGF-β Signaling Pathways and Disrupts EMT-Related Events in Human Lung Adenocarcinoma Cells.

Leonardo Marques da Fonseca, Lucas Rodrigues Jacques da Silva, Jhenifer Santos Dos Reis, Marcos André Rodrigues da Costa Santos, Victoria de Sousa Chaves, Kelli Monteiro da Costa, Julliana de Nazareth Sa-Diniz, Celio Geraldo Freire de Lima, Alexandre Morrot, Tatiany Nunes Franklim and 5 more

Open access · goldAbstract read
In one paragraph

Article in Medicines (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Hidden Power of Black Pepper: Exploring Piperine's Role in Cancer.Plant foods for human nutrition (Dordrecht, Netherlands) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Leonardo Marques da FonsecaLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Lucas Rodrigues Jacques da SilvaLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Jhenifer Santos Dos ReisLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Marcos André Rodrigues da Costa SantosLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Victoria de Sousa ChavesLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Kelli Monteiro da CostaLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Julliana de Nazareth Sa-DinizLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Celio Geraldo Freire de LimaLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Alexandre MorrotFaculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Tatiany Nunes FranklimInstituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica RJ 23851-970, Brazil.
Douglas Chaves de Alcântara-PintoInstituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica RJ 23851-970, Brazil.
Marco Edilson Freire de LimaInstituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica RJ 23851-970, Brazil.ORCID 0000-0003-0563-3483
Jose Osvaldo PreviatoLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.
Lucia Mendonça-PreviatoLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.ORCID 0000-0003-3927-3244
Leonardo Freire-de-LimaLaboratório de Glicobiologia, Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro RJ 21941-902, Brazil.ORCID 0000-0003-3013-3173
Universidade Federal do Rio de Janeiro · BRUniversidade Federal Rural do Rio de Janeiro · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 422100/2016-1Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/203.199/2017 (233.402)Fundação do Câncer 2016-2017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerepithelial–mesenchymal transitionERK1/2piperidinyl amidepiperineSMAD

Identifiers

PMID32276474
PMCPMC7235759
OpenAlexW3015943082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.